Minimally Invasive Parathyroidectomy Performed Under Loco‐Regional Anaesthesia Versus General Anaesthesia: A Systematic Review and Meta‐Analysis
ANZ Journal of Surgery · 2026
DOI: 10.1111/ans.70536 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift ANZ Journal of Surgery, 2026. Verfasst von Cian Casey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Launceston General Hospital, Launceston, Tasmania, Australia. Hauptthemen laut MEDLINE: Parathyroidectomy, Anesthesia, General, Minimally Invasive Surgical Procedures, Hyperparathyroidism, Primary. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Background
Traditionally bilateral cervical exploration (BCE) under general anaesthesia has been performed for cases of primary hyperparathyroidism (PHP) caused by a parathyroid adenoma. Imaging‐guided minimally invasive parathyroidectomy (MIP) has been shown to be equally efficacious with less morbidity. This systematic review and meta‐analysis aim to assess the safety and efficacy of MIP under locoregional anaesthesia (LRMIP) compared to general anaesthesia (GAMIP).
Methods
SCOPUS, Cochrane Library, PubMed and Google Scholar databases were searched from inception to August 2024 to identify eligible comparative studies investigating minimally invasive parathyroidectomy under locoregional anaesthesia (LRMIP) versus general anaesthesia (GAMIP). The primary outcomes were cure and side effects. Secondary outcomes were recurrent/persistent hyperparathyroidism, post‐operative nausea and vomiting, pain, use of analgesia, operating time, length of hospital stay, and patient satisfaction.
Results
Seven research articles were included, two RCTs and five cohort studies, including 1046 patients. Cure rates, side effect profile, and recurrent/persistent hyperparathyroidism were comparable between both groups. Trends towards reduced post‐operative nausea and vomiting were seen in LRMIP. The LRMIP group experienced a mean reduction of −1.26 for VAS pain scores ( p < 0.04) and required fewer analgesics. Patient satisfaction with LRMIP appears comparable to GAMIP.
Conclusion
LRMIP appears comparable to GAMIP in respect of cure and safety profile, with reduced pain and potential benefits in PONV and recovery. LRMIP may be considered for selected patients undergoing parathyroidectomy for primary hyperparathyroidism. Larger prospective studies are needed prior to broader adoption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of General Surgery, Launceston General Hospital, Launceston, Tasmania, Australia.
- Department of General Surgery, Fiona Stanley Hospital, Perth, Western Australia, Australia.
- Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.
- General Surgery and Gastrointestinal Clinical Institute, Epworth Healthcare, Melbourne, Victoria, Australia.
- Department of General Surgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Cian Casey, Nagendra N Dudi-Venkata
Zitieren
APA
Casey, C., Ramirez, R., Dudi-Venkata, N. N., Tasevski, R., & Bazaadut, S. (2026). Minimally Invasive Parathyroidectomy Performed Under Loco‐Regional Anaesthesia Versus General Anaesthesia: A Systematic Review and Meta‐Analysis. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70536
Vancouver
Casey C, Ramirez R, Dudi-Venkata NN, Tasevski R, Bazaadut S. Minimally Invasive Parathyroidectomy Performed Under Loco‐Regional Anaesthesia Versus General Anaesthesia: A Systematic Review and Meta‐Analysis. ANZ Journal of Surgery. 2026. doi:10.1111/ans.70536
BibTeX
@article{Casey2026,
author = {Casey, Cian and Ramirez, Rodolfo and Dudi-Venkata, Nagendra N and Tasevski, Robert and Bazaadut, Simon},
title = {Minimally Invasive Parathyroidectomy Performed Under Loco‐Regional Anaesthesia Versus General Anaesthesia: A Systematic Review and Meta‐Analysis},
journal = {ANZ Journal of Surgery},
year = {2026},
doi = {10.1111/ans.70536}
}
EUVIMED